Ciclosporin (Sandimmun) therapy: experience in the treatment of pars planitis and present therapeutic guidelines.
Nussenblatt
R B
RB
Laboratory of Immunology, National Eye Institute, Bethesda, Md.
Palestine
A G
AG
D000293:Adolescent; D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D015868:Pars Planitis / Q000188:drug therapy*; D016896:Treatment Outcome; D014792:Visual Acuity / Q000187:drug effects; D014822:Vitreous Body / Q000473:pathology
D016572:Cyclosporine; D003404:Creatinine